Jeff Zadoks
Analyst · Barclays. Please go ahead
Thanks, Rob, and good morning, everyone. Given the volatile macro backdrop and challenges associated with Avian influenza, we are especially pleased with our Q2 results. Our Foodservice team did a fantastic job navigating incredibly difficult egg markets as they prioritize customer supply while at the same time, mitigating some of the expected net cost impact. Meanwhile, our retail businesses offset volume pressures with cost control and supply chain execution. As a reminder, last quarter, we guided that Q2 would be down $30 million to $50 million compared to Q1 as a result of Avian influenza cost ahead of pricing impacts on Foodservice. Actual Q2 Foodservice adjusted EBITDA was approximately $20 million lower than Q1 as $30 million of costs ahead of pricing impact was partially offset by manufacturing and supply chain performance improvements. Setting aside the temporary impact of Avian influenza, underlying business trends versus last year remain encouraging despite a backdrop of poor foodservice foot traffic. Our selling proposition continues to prove out as our mix of higher value-added egg products grew once again. Looking to the balance of the fiscal year, additional Avian influenza pricing became effective starting in April, and our flock repopulation is on track. Assuming no additional outbreaks in our network, we expect to balance our egg sourcing and demand by Q4, and we continue to expect we will recover the unfavorable cost ahead of pricing impact we saw in Q2 during the remainder of fiscal '25. Moving on to Post Consumer Brands. We had a solid quarter while navigating volume declines in both grocery and pet. In grocery, our cost structure continued to benefit from last September's plant closure. However, the cereal category declines accelerated to down 3.7% with our branded portfolio slightly behind at down 4.5%. Category declines continue to pressure our manufacturing utilization and cost structure, which drove our recent decision to close two more plants by the end of the calendar year. Our pet volume consumption was down 4.5% versus a flat category as we continue to face declines in Nutrish demand and distribution and Gravy Train price elasticities. We were able to offset these lower pet volumes with improved supply chain and SG&A cost performance. Finally, a relaunch of the Nutrish brand is certainly hitting the shelves. And while it is very early, the first reactions are encouraging. Turning to Refrigerated Retail. Q2 adjusted EBITDA was down versus prior year primarily because of Easter timing, which fell during Q2 a year ago. In addition, similar to our Foodservice business, we experienced costs ahead of pricing in eggs with pricing taking effect in April, which will benefit Q3. Our focus continues to be on driving volumes in our sides business, driving lower costs and integrating our newly acquired PPI business. At Weetabix performance improved after our ERP conversion last quarter. While we see -- while we still limited promotional activities in Q2, we saw yellow box consumption relatively in line with the category, which was down 1.5%. We expect to improve margins in the back half of the year through sequential volume growth as we ramp up marketing with targeted activations and further execute our cost-out initiatives. Before turning the call over to Matt, a couple of comments on M&A and capital allocation. The recent tariff actions and volatility in capital markets have slowed what was an active M&A pipeline for us. The uncertainty in this environment points to smaller tactical transactions, such as our recent acquisition of PPI or transactions where we have clear line of sight to synergies. With that said, we have continued to lean into share repurchases and have now bought approximately 6% of the Company since the beginning of the fiscal year. From both the leverage and liquidity position, we remain very well positioned for opportunistic capital allocation. With that I’ll turn call over the Matt.